Inflammatory Bowel Diseases

Titel Veröffentlichungsdatum Sprache Zitate
Probiotic administration in patients with ileal pouch–anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells2008/05/01English138
Risk factors of anxiety and depression in inflammatory bowel disease2012/11/01English138
Postoperative recurrent luminal Crohnʼs Disease: A systematic review2012/04/01English138
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease2010/09/01English138
The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis2018/03/15English137
High incidence of inflammatory bowel disease in Australia: A prospective population-based Australian incidence study2010/09/01English137
Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysis2012/12/01English137
Pulmonary Manifestations of Inflammatory Bowel Disease2003/03/01English137
Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease2009/06/01English136
Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses—Part II2018/04/23English135
Increasing Fecal Butyrate in Ulcerative Colitis Patients by Diet: Controlled Pilot Study2003/03/01English135
Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis2007/02/01English134
Genetics of inflammatory bowel disease in Asia: Systematic review and meta-analysis2012/06/01English134
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis2009/11/01English133
Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro2012/03/01English132
Predictors of early response to infliximab in patients with ulcerative colitis2007/02/01English132
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy2011/09/01English132
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis2011/07/01English131
Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity2006/06/01English131
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study*2012/06/01English130
Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis2008/01/01English129
Predictive value of epithelial gene expression profiles for response to infliximab in Crohnʼs disease‡2010/12/01English129
Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease2009/08/01English128
Voluntary childlessness is increased in women with inflammatory bowel disease2007/05/01English127
Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitis2010/01/01English127
Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis2009/11/01English127
Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–20062011/12/01English125
Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review2012/07/01English125
Increased Expression of HIP/PAP and Regenerating Gene III in Human Inflammatory Bowel Disease and a Murine Bacterial Reconstitution Model2003/05/01English125
Impaired intestinal iron absorption in Crohnʼs disease correlates with disease activity and markers of inflammation2006/12/01English125